ARTICLE | Top Story
Scios, Quintiles in Natrecor alliance
January 11, 2001 8:00 AM UTC
QTRN will provide $35 million to commercialize SCIO's Natrecor nesiritide for acute decompensated congestive heart failure, with a $10 million payment to come within six months following launch of the...